Alta Partners (San Francisco, CA)
Ed joined Alta in 2002 and is a Director in Alta BioPharma III and Alta Partners VIII. He is currently on the board of directors of Calistoga Pharmaceuticals, Cara Therapeutics, FoldRx Pharmaceuticals, and MacroGenics and led Alta's investments in ChemoCentryx, Sunesis Pharmaceuticals and Threshold Pharmaceuticals. Prior to joining Alta, Ed served as Senior Vice President and CFO of Affymetrix from 1997 to 2002. From 1994 to 1997, Ed was a biotechnology research analyst for Robertson Stephens & Company, and from 1992 to 1994, was a biotechnology research analyst for Smith Barney Shearson. From 1990 to 1992, Ed practiced commercial law at Cooley Godward LLP.
Ed earned his Juris Doctor and Master of Business Administration degrees in 1990 from the University of California, Berkeley's Boalt School of Law and Haas School of Business, respectively. Ed earned a Bachelor of Arts in Molecular Biology from Cornell University in 1985.